There are over 50 million people worldwide living with dementia today, and this number is expected to reach 82 million by 2030. According to the World Alzheimer Report 2020, the global annual cost of dementia is estimated to be more than US$ 1 trillion and is forecasted to double by 2030. We believe that Europe as a whole has the most up-to-date scientific and clinical knowledge to understand the complexities of neurodegeneration and to develop new technological and therapeutic innovations. Europe has long been a major driver of global innovation but has recently lagged behind in growth sectors and in areas of innovation such as genomics, quantum computing and artificial intelligence.
CLARA will use Europe’s full potential and contribute to change.